Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a fully integrated commercial biotechnology company, announced that its management team will participate in two upcoming investor conferences in May 2026: the RBC Capital Markets Global Healthcare Conference on May 19 in New York and A.G.P.’s Annual Virtual Healthcare Conference on May 20. These presentations provide an opportunity for the company to discuss its recent milestones and pipeline developments with investors and industry analysts.
The conferences come on the heels of significant progress for Tonix. In 2025, the company received FDA approval for TONMYA (cyclobenzaprine HCl sublingual tablets 2.8mg), the first new treatment for fibromyalgia in over 15 years. This approval marks a turning point for the company, as it transitions into a commercial-stage entity with a dedicated CNS sales force. Tonix is now leveraging this infrastructure to support its marketed products, including acute migraine treatments Zembrace SymTouch and Tosymra.
Beyond its commercial portfolio, Tonix is actively exploring the potential of TONMYA in other indications. Phase 2 clinical trials are underway to evaluate its efficacy in major depressive disorder and acute stress disorder, conditions with high unmet medical need. The company’s CNS pipeline also includes TNX-2900, a Phase 2-ready therapy for Prader-Willi syndrome, a rare genetic disorder. In immunology, Tonix is advancing TNX-4800, a monoclonal antibody for Lyme disease prophylaxis, and TNX-1500, a third-generation CD40 ligand inhibitor designed to prevent kidney transplant rejection.
The investor conferences will allow Tonix to highlight these programs and its strategic focus on central nervous system and immunology treatments. For more details, the full press release is available at https://ibn.fm/ZZpG2. Investors can also find the latest updates on TNXP in the company’s newsroom at https://ibn.fm/TNXP.
Tonix’s participation in these conferences underscores its commitment to advancing treatments for areas of high unmet need and communicating its progress to the investment community. The RBC Capital Markets conference, in particular, is a key event for healthcare investors, while A.G.P.’s virtual format broadens accessibility.
